# Macro and Microcirculatory Effects of the Combination of Norepinephrine and Octreotide for the Treatment of Cirrhotic Patients With Hemorrhagic Shock

> **NCT03891849** · NA · WITHDRAWN · sponsor: **Centre Hospitalier Universitaire, Amiens**

## Conditions studied

- Haemorrhagic Shock
- Variceal Hemorrhage

## Interventions

- **DRUG:** Octreotide Injection

## Key facts

- **NCT ID:** NCT03891849
- **Lead sponsor:** Centre Hospitalier Universitaire, Amiens
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2021-09-01
- **Primary completion:** 2023-05
- **Final completion:** 2023-05
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** No participant enrolled. Equipment unvailable.
- **Last updated:** 2023-02-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03891849

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03891849, "Macro and Microcirculatory Effects of the Combination of Norepinephrine and Octreotide for the Treatment of Cirrhotic Patients With Hemorrhagic Shock". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT03891849. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*